{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:52:52Z","timestamp":1793213572473,"version":"4.5.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.tins.2023.07.005","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T08:16:03Z","timestamp":1692260163000},"page":"863-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component"],"prefix":"10.1016","volume":"46","author":[{"given":"Johanne","family":"Lauritsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0970-578X","authenticated-orcid":false,"given":"Marina","family":"Romero-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2023.07.005_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40478-022-01440-6","article-title":"Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease","volume":"10","author":"Sekiya","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","article-title":"Parkinson's disease outside the brain: targeting the autonomic nervous system","volume":"20","author":"Sharabi","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11910-016-0655-4","article-title":"Imaging systemic dysfunction in Parkinson's disease","volume":"16","author":"Borghammer","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.tins.2023.07.005_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tins.2023.07.005_bb0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0035","article-title":"Genetic overlap between Parkinson's disease and inflammatory bowel disease","volume":"5","author":"Kang","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0040","article-title":"Molecular communication between neuronal networks and intestinal epithelial cells in gut inflammation and Parkinson's disease","volume":"8","author":"Drobny","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tins.2023.07.005_bb0045","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3233\/JPD-223176","article-title":"Immunogenetic determinants of Parkinson's disease etiology","volume":"12","author":"Kung","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0050","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/hmg\/ddab294","article-title":"Fine-mapping of Parkinson's disease susceptibility loci identifies putative causal variants","volume":"31","author":"Schilder","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2023.07.005_bb0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smajic","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0060","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41467-019-08912-9","article-title":"Prioritizing Parkinson's disease genes using population\u2013scale transcriptomic data","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnins.2020.00193","article-title":"Leucine rich repeat kinase 2 and innate immunity","volume":"14","author":"Ahmadi Rastegar","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fnins.2020.00227","article-title":"The emerging functions of LRRK2 and Rab GTPases in the endolysosomal system","volume":"14","author":"Kuwahara","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BCJ20170803","article-title":"Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils","volume":"475","author":"Fan","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.tins.2023.07.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021519","article-title":"Regulation of LRRK2 expression points to a functional role in human monocyte maturation","volume":"6","author":"Thevenet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2023.07.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039132","article-title":"The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling","volume":"7","author":"Dzamko","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2023.07.005_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798694","article-title":"LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages","volume":"37","author":"Hartlova","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.tins.2023.07.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9292","article-title":"Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner","volume":"11","author":"Shutinoski","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2023.07.005_bb0100","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/brain\/awy077","article-title":"Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo","volume":"141","author":"Kozina","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41531-021-00170-1","article-title":"Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease?","volume":"7","author":"Herrick","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","article-title":"LRRK2 levels in immune cells are increased in Parkinson's disease","volume":"3","author":"Cook","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.27601","article-title":"LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients","volume":"34","author":"Atashrazm","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","article-title":"Parkinson's disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation","volume":"166","author":"Matheoud","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tins.2023.07.005_bb0125","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/glia.23337","article-title":"Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop","volume":"66","author":"Mouton-Liger","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.tins.2023.07.005_bb0130","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/eji.201343571","article-title":"Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function","volume":"43","author":"Ellis","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0135","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fimmu.2019.01069","article-title":"Mitochondrial protein PINK1 positively regulates RLR signaling","volume":"10","author":"Zhou","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson's disease-like symptoms in Pink1(-\/-) mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.07.005_bb0145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.07.005_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12974-016-0632-5","article-title":"Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model","volume":"13","author":"Sommer","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","article-title":"T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an alpha-synuclein rat model of Parkinson's disease","volume":"17","author":"Subbarayan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","article-title":"Neurodegeneration by alpha-synuclein-specific T cells in AAV-A53T-alpha-synuclein Parkinson's disease mice","volume":"101","author":"Karikari","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.07.005_bb0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","article-title":"Peripheral monocyte entry is required for alpha-synuclein induced inflammation and neurodegeneration in a model of Parkinson disease","volume":"300","author":"Harms","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0175","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear alpha-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of alpha-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.07.005_bb0180","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson's disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0190","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in Parkinson's disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tins.2023.07.005_bb0195","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s43587-021-00110-x","article-title":"Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells","volume":"1","author":"Navarro","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.tins.2023.07.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128651","article-title":"Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson's disease","volume":"10","author":"Dijkstra","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2023.07.005_bb0205","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","article-title":"Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study","volume":"16","author":"Stokholm","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11910-019-0934-y","article-title":"New and old TSPO PET radioligands for imaging brain microglial activation in neurodegenerative disease","volume":"19","author":"Best","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.tins.2023.07.005_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105027","article-title":"Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: a case series","volume":"144","author":"Joers","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00259-021-05379-z","article-title":"TSPO imaging in animal models of brain diseases","volume":"49","author":"Van Camp","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tins.2023.07.005_bb0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","article-title":"Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study","volume":"30","author":"Terada","year":"2016","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.tins.2023.07.005_bb0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2018.00247","article-title":"Microglia response during Parkinson's disease: alpha-synuclein intervention","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","article-title":"Toll-like receptors and their therapeutic potential in Parkinson's disease and alpha-synucleinopathies","volume":"81","author":"Kouli","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.07.005_bb0240","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","article-title":"Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease","volume":"98","author":"Luchtman","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.tins.2023.07.005_bb0250","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0255","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bpa.12137","article-title":"Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson's disease brain is region dependent","volume":"24","author":"Garcia-Esparcia","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578019","article-title":"Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease","volume":"375","author":"Pereira","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13094","article-title":"Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.tins.2023.07.005_bb0270","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/brain\/awab122","article-title":"Reactive microglia enhance the transmission of exosomal alpha-synuclein via toll-like receptor 2","volume":"144","author":"Xia","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease","volume":"14","author":"George","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2023.07.005_bb0280","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s43587-021-00088-6","article-title":"RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson\u2019s disease","volume":"1","author":"Craig","year":"2021","journal-title":"Nature Aging"},{"key":"10.1016\/j.tins.2023.07.005_bb0285","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.26034","article-title":"Lower lymphocyte count is associated with increased risk of Parkinson's disease","volume":"89","author":"Jensen","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41531-021-00271-x","article-title":"Specific immune status in Parkinson's disease at different ages of onset","volume":"8","author":"Tian","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-022-00554-8","article-title":"Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson's disease","volume":"17","author":"Riboldi","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2023.07.005_bb0300","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1523\/JNEUROSCI.1636-16.2016","article-title":"Anti-inflammatory modulation of microglia via CD163-targeted glucocorticoids protects dopaminergic neurons in the 6-OHDA Parkinson's disease model","volume":"36","author":"Tentillier","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0305","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0310","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s13311-020-00877-8","article-title":"Neuroprotective activities of long-acting granulocyte-macrophage colony-stimulating factor (mPDM608) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice","volume":"17","author":"Olson","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tins.2023.07.005_bb0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fncel.2019.00421","article-title":"A synthetic agonist to vasoactive intestinal peptide receptor-2 induces regulatory t cell neuroprotective activities in models of Parkinson's disease","volume":"13","author":"Mosley","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0320","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40035-023-00361-1","article-title":"An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers","volume":"12","author":"Olson","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tins.2023.07.005_bb0325","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbi.2009.01.018","article-title":"Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease","volume":"23","author":"Engler","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.07.005_bb0330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12640-017-9712-2","article-title":"Complex changes in the innate and adaptive immunity accompany progressive degeneration of the nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine in the rat","volume":"32","author":"Ambrosi","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.tins.2023.07.005_bb0335","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2016.09.013","article-title":"Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease","volume":"286","author":"Mulas","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0350","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fneur.2019.00232","article-title":"Peripheral\u2013central neuroimmune crosstalk in Parkinson's disease: what do patients and animal models tell us?","volume":"10","author":"Fuzzati-Armentero","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0355","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0360","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JPD-191724","article-title":"Senescence and inflammatory markers for predicting clinical progression in Parkinson's disease: the ICICLE-PD study","volume":"10","author":"Martin-Ruiz","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0365","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020858118","article-title":"Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder","volume":"118","author":"Farmen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.07.005_bb0370","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2016.01.019","article-title":"In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects","volume":"54","author":"Kanegawa","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.07.005_bb0375","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/brain\/awy265","article-title":"Early microglial activation and peripheral inflammation in dementia with Lewy bodies","volume":"141","author":"Surendranathan","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0380","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-022-02574-z","article-title":"Brain microglia activation and peripheral adaptive immunity in Parkinson's disease: a multimodal PET study","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0385","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson's disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0390","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbi.2020.01.018","article-title":"Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease","volume":"87","author":"Wijeyekoon","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.07.005_bb0395","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2022.01.005","article-title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition","volume":"101","author":"Konstantin Nissen","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.07.005_bb0400","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2021.02.017","article-title":"Abnormal subpopulations of monocytes in the cerebrospinal fluid of patients with Parkinson's disease","volume":"84","author":"Pillny","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0405","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","article-title":"Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease","volume":"7","author":"Thome","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0410","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/mds.27815","article-title":"Alterations in blood monocyte functions in Parkinson's disease","volume":"34","author":"Nissen","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0415","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1007\/s00415-022-11258-w","article-title":"Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson's disease","volume":"269","author":"Su","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0420","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fneur.2018.00870","article-title":"Monocyte function in Parkinson's disease and the impact of autologous serum on phagocytosis","volume":"9","author":"Wijeyekoon","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0425","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fimmu.2020.01070","article-title":"Human monocyte subset distinctions and function: insights from gene expression analysis","volume":"11","author":"Cormican","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0430","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/mds.28424","article-title":"Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson's disease","volume":"36","author":"Nissen","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0435","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tins.2023.07.005_bb0440","doi-asserted-by":"crossref","first-page":"637","DOI":"10.21037\/atm.2019.10.105","article-title":"Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson's disease","volume":"7","author":"Sun","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.tins.2023.07.005_bb0445","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fneur.2018.00234","article-title":"Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease","volume":"9","author":"Sanjari Moghaddam","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0450","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41531-023-00457-5","article-title":"Peripheral inflammatory immune response differs among sporadic and familial Parkinson's disease","volume":"9","author":"Munoz-Delgado","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JPD-223454","article-title":"Transcriptome analysis reveals a two-gene signature links to motor progression and alterations of immune cells in Parkinson's disease","volume":"13","author":"Li","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0460","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3390\/jcm11195543","article-title":"Lymphocyte count and neutrophil-to-lymphocyte ratio are associated with mild cognitive impairment in Parkinson's disease: a single-center longitudinal study","volume":"11","author":"Contaldi","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tins.2023.07.005_bb0465","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0470","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2023.07.005_bb0475","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-018-1286-2","article-title":"Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha\u2013synuclein model of Parkinson's disease","volume":"15","author":"Williams","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0480","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12974-018-1206-5","article-title":"Abnormalities of age-related T cell senescence in Parkinson's disease","volume":"15","author":"Williams-Gray","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0485","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12974-021-02287-9","article-title":"T lymphocyte senescence is attenuated in Parkinson's disease","volume":"18","author":"Kouli","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0490","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tins.2023.07.005_bb0495","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153302","article-title":"DJ-1 depletion prevents immunoaging in T-cell compartments","volume":"23","author":"Zeng","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tins.2023.07.005_bb0500","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tins.2023.07.005_bb0505","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","article-title":"Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson's disease","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.tins.2023.07.005_bb0510","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0515","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12974-021-02296-8","article-title":"T-cell dysregulation is associated with disease severity in Parkinson's Disease","volume":"18","author":"Bhatia","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0520","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.28137","article-title":"CD4+ T-cell transcription factors in idiopathic REM sleep behavior disorder and Parkinson's disease","volume":"36","author":"De Francesco","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0525","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","article-title":"Immune cell activation in the cerebrospinal fluid of patients with Parkinson's disease","volume":"9","author":"Schroder","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0530","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41420-023-01333-0","article-title":"Time-resolved RNA signatures of CD4+ T cells in Parkinson's disease","volume":"9","author":"Diener","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tins.2023.07.005_bb0535","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001036","article-title":"Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.tins.2023.07.005_bb0540","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1007\/s00415-022-11190-z","article-title":"Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson's disease","volume":"269","author":"He","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0545","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"Alvarez-Luquin","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0550","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","article-title":"Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tins.2023.07.005_bb0555","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tins.2023.07.005_bb0560","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41531-022-00438-0","article-title":"Impaired migratory phenotype of CD4(+) T cells in Parkinson's disease","volume":"8","author":"Mamula","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0565","article-title":"(2020) alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease","volume":"11","author":"Lindestam Arlehamn","year":"1875","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0570","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.07.005_bb0575","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1801506","article-title":"Widespread Tau-specific CD4 T cell reactivity in the general population","volume":"203","author":"Lindestam Arlehamn","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120510","article-title":"Unaltered T cell responses to common antigens in individuals with Parkinson's disease","volume":"444","author":"Williams","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tins.2023.07.005_bb0585","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0590","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-022-00282-2","article-title":"Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures","volume":"8","author":"Dhanwani","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0595","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.18632\/aging.100859","article-title":"Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients","volume":"7","author":"Horvath","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.tins.2023.07.005_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.572205","article-title":"Imbalance of circulating Tfh\/Tfr cells in patients with Parkinson's disease","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0605","article-title":"Global characterization of peripheral B cells in Parkinson's disease by single\u2013cell RNA and BCR sequencing","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0610","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001125","article-title":"Abnormal B-cell and Tfh-cell profiles in patients with Parkinson disease: a cross-sectional study","volume":"9","author":"Li","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.tins.2023.07.005_bb0615","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00401-019-01974-5","article-title":"Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology","volume":"137","author":"Li","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0620","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/jnc.14330","article-title":"Measurements of auto-antibodies to alpha-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease","volume":"145","author":"Akhtar","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2023.07.005_bb0625","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-017-0187-7","article-title":"Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies","volume":"12","author":"Brudek","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2023.07.005_bb0630","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2021.05.001","article-title":"Cerebrospinal fluid and plasma distribution of anti-alpha-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease","volume":"87","author":"Folke","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0635","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/NEN.0b013e31829768d2","article-title":"alpha-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model","volume":"72","author":"Sanchez-Guajardo","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2023.07.005_bb0645","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/cells11101649","article-title":"Parkinson's disease-specific autoantibodies against the neuroprotective co-chaperone STIP1","volume":"11","author":"Tan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tins.2023.07.005_bb0650","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-022-02491-8","article-title":"Stress-inducible phosphoprotein 1 (HOP\/STI1\/STIP1) regulates the accumulation and toxicity of alpha-synuclein in vivo","volume":"144","author":"Lackie","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0655","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.expneurol.2009.03.002","article-title":"Anti-melanin antibodies are increased in sera in Parkinson's disease","volume":"217","author":"Double","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0660","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2202-12-116","article-title":"Neuromelanin is an immune stimulator for dendritic cells in vitro","volume":"12","author":"Oberlander","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0665","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0670","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.26090","article-title":"Investigation of autosomal genetic sex differences in Parkinson's disease","volume":"90","author":"Blauwendraat","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0675","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mds.28312","article-title":"Differences in the presentation and progression of Parkinson's disease by sex","volume":"36","author":"Iwaki","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2023.07.005_bb0680","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2023.05.013","article-title":"Disruption of alpha-synuclein proteostasis in the striatum and midbrain of Long-term ovariectomized female mice","volume":"523","author":"Zhou","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2023.07.005_bb0685","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.3390\/ijms20246251","article-title":"Delayed dopamine dysfunction and motor deficits in female Parkinson model mice","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tins.2023.07.005_bb0690","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","article-title":"Sex-specific features of microglia from adult mice","volume":"23","author":"Villa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2023.07.005_bb0695","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.celrep.2018.08.001","article-title":"Transcriptional and translational differences of microglia from male and female brains","volume":"24","author":"Guneykaya","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2023.07.005_bb0700","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211488","article-title":"The X factor in neurodegeneration","volume":"219","author":"Voskuhl","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tins.2023.07.005_bb0705","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/genes9060275","article-title":"Sex-specific transcriptome differences in substantia nigra tissue: a meta-analysis of Parkinson's disease data","volume":"9","author":"Mariani","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.tins.2023.07.005_bb0710","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13293-022-00477-5","article-title":"Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies","volume":"13","author":"Lopez-Cerdan","year":"2022","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.tins.2023.07.005_bb0715","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41588-021-00976-y","article-title":"Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies","volume":"54","author":"Lopes","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tins.2023.07.005_bb0720","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0725","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41467-020-14396-9","article-title":"Sexual-dimorphism in human immune system aging","volume":"11","author":"Marquez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0730","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12979-021-00214-3","article-title":"Sex- and age-dependent alterations of splenic immune cell profile and NK cell phenotypes and function in C57BL\/6J mice","volume":"18","author":"Menees","year":"2021","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.tins.2023.07.005_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.686066","article-title":"Significant difference of immune cell fractions and their correlations with differential expression genes in Parkinson's disease","volume":"13","author":"Huang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2023.07.005_bb0740","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41531-021-00274-8","article-title":"Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients","volume":"8","author":"Meoni","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0745","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41531-021-00180-z","article-title":"Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease","volume":"7","author":"Carlisle","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0750","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40478-021-01240-4","article-title":"Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology","volume":"9","author":"Houser","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0755","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/jnr.25067","article-title":"NURR1-deficient mice have age- and sex-specific behavioral phenotypes","volume":"100","author":"Montarolo","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tins.2023.07.005_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102307","article-title":"alpha-synucleinopathy exerts sex-dimorphic effects on the multipurpose DNA repair\/redox protein APE1 in mice and humans","volume":"216","author":"Miner","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tins.2023.07.005_bb0765","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/glia.24255","article-title":"Microglial angiotensin type 2 receptors mediate sex-specific expression of inflammatory cytokines independently of circulating estrogen","volume":"70","author":"Garrido-Gil","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.tins.2023.07.005_bb0770","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev-immunol-042617-053158","article-title":"Molecular and functional neuroscience in immunity","volume":"36","author":"Pavlov","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0775","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/brain\/awab061","article-title":"Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats","volume":"144","author":"Van Den Berge","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102177","article-title":"Gut microbiome-mediated regulation of neuroinflammation","volume":"76","author":"Bostick","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0785","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0790","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.07.005_bb0795","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","article-title":"Consequences of variability in alpha-synuclein fibril structure on strain biology","volume":"143","author":"Holec","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0800","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.07.005_bb0805","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-022-01468-8","article-title":"Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders","volume":"10","author":"Altay","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0810","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble alpha-synuclein aggregates are the toxic species in Parkinson's disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0815","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0820","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-021-02316-0","article-title":"Multiple system atrophy-associated oligodendroglial protein p25alpha stimulates formation of novel alpha-synuclein strain with enhanced neurodegenerative potential","volume":"142","author":"Ferreira","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.07.005_bb0825","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.25557","article-title":"Increased immune activation by pathologic alpha-synuclein in Parkinson's disease","volume":"86","author":"Grozdanov","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2023.07.005_bb0830","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-022-01342-7","article-title":"Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-beta and alpha-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies","volume":"10","author":"Fixemer","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2023.07.005_bb0835","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/glia.24295","article-title":"Microglia and astrocyte activation is region-dependent in the alpha-synuclein mouse model of Parkinson's disease","volume":"71","author":"Basurco","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.tins.2023.07.005_bb0840","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphar.2015.00171","article-title":"Adrenergic regulation of innate immunity: a review","volume":"6","author":"Scanzano","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tins.2023.07.005_bb0845","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.3390\/ijms21228630","article-title":"Locus coeruleus modulates neuroinflammation in parkinsonism and dementia","volume":"21","author":"Giorgi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tins.2023.07.005_bb0850","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11481-019-09834-5","article-title":"Targeting the dopaminergic system in autoimmunity","volume":"15","author":"Vidal","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.tins.2023.07.005_bb0855","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151892","article-title":"Functional characterization of the biogenic amine transporters on human macrophages","volume":"7","author":"Mackie","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.tins.2023.07.005_bb0860","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41531-022-00333-8","article-title":"DAT and TH expression marks human Parkinson's disease in peripheral immune cells","volume":"8","author":"Gopinath","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tins.2023.07.005_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577328","article-title":"Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: a two-year prospective study","volume":"347","author":"Espinosa-Cardenas","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.tins.2023.07.005_bb0870","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12967-021-03055-2","article-title":"Increased Tc17 cell levels and imbalance of naive\/effector immune response in Parkinson's disease patients in a two-year follow-up: a case control study","volume":"19","author":"Alvarez-Luquin","year":"2021","journal-title":"J. Transl. Med."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223623001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223623001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:24:18Z","timestamp":1759062258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223623001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":174,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0166223623001650"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2023.07.005","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2023.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}